Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    22067397 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)
Conditions: Leiomyosarcoma;   Liposarcoma;   Osteosarcoma;   Sarcoma, Soft Tissue;   Metastases
Intervention: Drug: ridaforolimus

Study has passed its completion date and status has not been verified in more than two years.